<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?covid-19-tdm?>
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">823253</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2021.823253</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Structural Insights Into Tautomeric Dynamics in Nucleic Acids and in Antiviral Nucleoside Analogs</article-title>
<alt-title alt-title-type="left-running-head">Fedeles et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Tautomerism in Nucleic Acids and Antivirals</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fedeles</surname>
<given-names>Bogdan I.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1590063/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Deyu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/742572/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Singh</surname>
<given-names>Vipender</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1260292/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Departments of Chemistry and Biological Engineering and Center for Environmental Health Sciences</institution>, <institution>Massachusetts Institute of Technology</institution>, <addr-line>Cambridge</addr-line>, <addr-line>MA</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Pharmaceutical Sciences</institution>, <institution>College of Pharmacy</institution>, <institution>University of Rhode Island</institution>, <addr-line>Kingston</addr-line>, <addr-line>RI</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Biochemistry and Biophysics</institution>, <institution>Novartis Institute of Biomedical Research</institution>, <addr-line>Cambridge</addr-line>, <addr-line>MA</addr-line>, <country>United&#x20;States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/124901/overview">Annalisa Pastore</ext-link>, King&#x2019;s College London, United&#x20;Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1405419/overview">Pablo D. Dans</ext-link>, Institut Pasteur de Montevideo, Uruguay</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1123373/overview">Pierre Barraud</ext-link>, UMR8261 Expression G&#xe9;n&#xe9;tique Microbienne, France</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Vipender Singh, <email>vipender02118@gmail.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Structural Biology, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>823253</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>12</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Fedeles, Li and Singh.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Fedeles, Li and Singh</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>DNA (2&#x2032;-deoxyribonucleic acid) and RNA (ribonucleic acid) play diverse functional roles in biology and disease. Despite being comprised primarily of only four cognate nucleobases, nucleic acids can adopt complex three-dimensional structures, and RNA in particular, can catalyze biochemical reactions to regulate a wide variety of biological processes. Such chemical versatility is due in part to the phenomenon of nucleobase tautomerism, whereby the bases can adopt multiple, yet distinct isomeric forms, known as tautomers. For nucleobases, tautomers refer to structural isomers that differ from one another by the position of protons. By altering the position of protons on nucleobases, many of which play critical roles for hydrogen bonding and base pairing interactions, tautomerism has profound effects on the biochemical processes involving nucleic acids. For example, the transient formation of minor tautomers during replication could generate spontaneous mutations. These mutations could arise from the stabilization of mismatches, in the active site of polymerases, in conformations involving minor tautomers that are indistinguishable from canonical base pairs. In this review, we discuss the evidence for tautomerism in DNA, and its consequences to the fidelity of DNA replication. Also reviewed are RNA systems, such as the riboswitches and self-cleaving ribozymes, in which tautomerism plays a functional role in ligand recognition and catalysis, respectively. We also discuss tautomeric nucleoside analogs that are efficacious as antiviral drug candidates such as molnupiravir for coronaviruses and KP1212 for HIV. The antiviral efficacy of these analogs is due, in part, to their ability to exist in multiple tautomeric forms and induce mutations in the replicating viral genomes. From a technical standpoint, minor tautomers of nucleobases are challenging to identify directly because they are rare and interconvert on a fast, millisecond to nanosecond, time scale. Nevertheless, many approaches including biochemical, structural, computational and spectroscopic methods have been developed to study tautomeric dynamics in RNA and DNA systems, and in antiviral nucleoside analogs. An overview of these methods and their applications is included&#x20;here.</p>
</abstract>
<kwd-group>
<kwd>Tautomerism</kwd>
<kwd>ribozymes</kwd>
<kwd>riboswitches</kwd>
<kwd>mutagenesis</kwd>
<kwd>COVID-19</kwd>
<kwd>antivirals</kwd>
<kwd>nucleoside analogs therapy</kwd>
<kwd>spontaenous mutations</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Nucleic acid bases exhibit keto-enol and amino-imino prototropic tautomerism due to the presence of multiple solvent-exchangeable protons (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>) (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B8">Brown et&#x20;al., 1989</xref>; <xref ref-type="bibr" rid="B12">Colominas et&#x20;al., 1996</xref>; <xref ref-type="bibr" rid="B40">Mons et&#x20;al., 2002</xref>). The formation of minor tautomers can increase the overall structural and chemical diversity of nucleic acids, which enables their diverse functions in biology (<xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B10">Cochrane and Strobel, 2008a</xref>; <xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). For example, many self-cleaving ribozymes (RNA enzymes) and some riboswitches (RNA aptamers) are proposed to utilize tautomerism to perform their biological function (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>, <xref ref-type="fig" rid="F3">Figure&#x20;3</xref>) (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). Formation of minor tautomers in DNA, at low frequency, is proposed to contribute to the phenomenon of &#x2018;spontaneous mutagenesis&#x2019;, which denotes the background level of mutations that appear during the replication of undamaged DNA (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). These mutations are thought to arise due, in part, to the altered base pairing properties of minor tautomers (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>) (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Prototropic tautomerism in cytosine. Nucleic acid bases contain keto, amino, or both functional groups. These groups often participate in keto-enol and amino-imino tautomerism as shown here for the native base cytosine.</p>
</caption>
<graphic xlink:href="fmolb-08-823253-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Tautomerism in riboswitches. <bold>(A)</bold> Top left, crystal structure of the purine riboswitch with xanthine in its binding pocket interacting with carbonyl oxygens of C74, U47 and U51, and a water molecule. Bottom left, all possible tautomeric forms of xanthosine. <bold>(B)</bold> Crystal structures of the TPP riboswitch showing interactions of its binding site G28 (guanosine at the 28th position) with the thiamine pyrophosphate (TPP) and oxythiamine pyrophosphate (OxyTPP) ligands. Bottom, tautomeric forms of oxythiamine identified by NMR and vibrational spectroscopy (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). The figure is adapted from reference (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>) (CC BY 4.0).</p>
</caption>
<graphic xlink:href="fmolb-08-823253-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Mechanism of the nucleolytic reaction catalyzed by small self-cleaving ribozymes. <bold>(A)</bold> Acid-base catalytic mechanism of small self-cleaving ribozymes and the positions of participating catalytic guanosines in the active sites of the respective ribozymes. <bold>(B)</bold> Catalytic guanosine (G33) in the active site of the <italic>glmS</italic> ribozyme, in close proximity to the 2&#x2032;-hydroxyl of the A-1 nucleotide adjacent to the scissile phosphodiester bond. <bold>(C)</bold> The N1 of catalytic guanosine (G8) in the hairpin ribozyme in close proximity to the 2&#x2032;-hydroxyl of the A-1 nucleotide. <bold>(D)</bold> The N1 of catalytic guanosine (G12) in the hammerhead ribozyme in close proximity to the 2&#x2032;-hydroxyl of the A-1 nucleotide. <bold>(E)</bold> The N1 of the catalytic guanosine (G698) in the Varkud Satellite ribozyme in close proximity the 2&#x2032;-hydroxyl of A-1 nucleotide. <xref ref-type="fig" rid="F3">Figure&#x20;3E</xref> was shared by Joe Piccirilli&#x2019;s laboratory at the University of Chicago (<xref ref-type="bibr" rid="B58">Suslov et&#x20;al., 2015</xref>), and parts of the figure are adapted from reference (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>) (CC BY 4.0).</p>
</caption>
<graphic xlink:href="fmolb-08-823253-g003.tif"/>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Proposed mechanism by which &#x201c;spontaneous&#x201d; mutations are introduced by the inter-strand movement of protons in Watson-Crick (W&#x2013;C) base pairs during replication. <bold>(A)</bold> Spontaneous transfer of two protons from one strand to another in A-T and G-C base pairs generate minor tautomers, which can form mismatches during replication to cause mutations. <bold>(B)</bold> Structural evidence for the stabilization of A-C base pair in W-C conformation, almost indistinguishable from the A-T base pair in active site of a high fidelity DNA polymerase. Figure is adapted from reference (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B70">Slocombe et&#x20;al., 2021</xref>).</p>
</caption>
<graphic xlink:href="fmolb-08-823253-g004.tif"/>
</fig>
<p>Therapeutics based on tautomeric nucleoside analogs have proven effective as antiviral agents against a range of retro- and ribo-viruses, including influenza (<xref ref-type="bibr" rid="B14">Delang et&#x20;al., 2018</xref>), hepatitis-C-virus (HCV) (<xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>), human immunodeficiency virus (HIV) (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>) and coronaviruses, including COVID-19 (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>) (<xref ref-type="bibr" rid="B54">Shannon et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). The antiviral efficacy of these analogs stems from their ability to exist in multiple tautomeric or rotameric states, which help mutagenize the viral genomes to error catastrophe and even to viral population extinction. The formation of minor tautomers in nucleic acids is a rare event, and their dynamics of interconversion is fast, on a millisecond to nanosecond time scale (<xref ref-type="bibr" rid="B44">Peng et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>). Recent developments in methods have allowed direct identification and quantification of minor tautomers in nucleic acid bases and in nucleoside/nucleotide analogs (<xref ref-type="bibr" rid="B46">Peng et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Proposed tautomeric structures of antiviral drugs molnupiravir and KP1212, and base pairing properties during replication in SARS-CoV-2 and HIV viruses, respectively (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>).</p>
</caption>
<graphic xlink:href="fmolb-08-823253-g005.tif"/>
</fig>
<p>Small self-cleaving ribozymes and many riboswitches are proposed to utilize minor tautomeric forms of catalytic residues and ligands to perform their biological functions (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>, <xref ref-type="fig" rid="F3">Figure&#x20;3</xref>) (<xref ref-type="bibr" rid="B9">Cochrane et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B10">Cochrane and Strobel, 2008a</xref>; <xref ref-type="bibr" rid="B11">Cochrane and Strobel, 2008b</xref>; <xref ref-type="bibr" rid="B61">Thore et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B67">Wilcox and Bevilacqua, 2013</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). Among riboswitches, crystallographic evidence shows that the purine and the thiamine pyrophosphate riboswitches recognize the minor tautomeric forms of their non-natural ligands xanthine and oxythiamine pyrophosphate (OxyTPP), respectively (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>) (<xref ref-type="bibr" rid="B61">Thore et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). Self-cleaving ribozymes such as hammerhead, hairpin, glmS, varkud satellite (VS), hepatitis delta virus (HDV), and twister catalyze nucleolytic intramolecular self-scission reactions (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>) (<xref ref-type="bibr" rid="B52">Rupert and Ferr&#xe9;-D&#x27;Amar&#xe9;, 2001</xref>; <xref ref-type="bibr" rid="B37">Martick and Scott, 2006</xref>; <xref ref-type="bibr" rid="B9">Cochrane et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B10">Cochrane and Strobel, 2008a</xref>; <xref ref-type="bibr" rid="B58">Suslov et&#x20;al., 2015</xref>). In these ribozymes, it is proposed that the tautomeric forms of their catalytic guanosines act as a general base to activate the 2&#x2032;-hydroxyl nucleophile to initiate the cleavage reactions (<xref ref-type="bibr" rid="B28">Klein et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B10">Cochrane and Strobel, 2008a</xref>).</p>
<p>During DNA replication, formation of minor tautomeric forms of nucleobases could lead to mispairing that generates mutations in the absence of any DNA lesion or other form of DNA damage (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B35">L&#xf6;wdin, 1963</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B6">Bebenek et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). This phenomenon is thought to explain the appearance of spontaneous mutations during the replication of undamaged DNA. The transient generation of minor tautomers in DNA allows stabilization of mismatches, in the polymerase active site, in conformations that are indistinguishable from the structures of canonical base pairs (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>) (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>).</p>
<p>While assembling their double-helix model of DNA, James Watson and Francis Crick stumbled over the phenomenon of base tautomerism; in fact, their model required that the bases adopt specific tautomeric forms in order to base-pair, with the suggestion that alternate tautomers would lead to mispairing and spontaneous mutations. (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>). These ideas were later formalized by Michael Topal and Jacques Fresco, who described in 1976 the specific pairings between the minor tautomeric forms of canonical nucleic acid bases during replication that are likely to lead to mutations (<xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>). Since then, structural studies have shown that the formation of minor tautomers in DNA could allow wobble mismatches, such as the A-C and G-T base pairs, to adopt a geometry similar to that of canonical base pairs in Watson and Crick (W-C) conformations (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>) (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B59">Szymanski et&#x20;al., 2017</xref>). These studies provided structural evidence in support of the rare tautomer hypothesis for spontaneous mutations (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>). Furthermore, tautomeric dynamics occur on a time scale that is similar to that of DNA replication, suggesting that the rate of rare tautomer formation could determine the probability of base misincorporation during replication (<xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>).</p>
<p>In this review, we will discuss mechanisms involving tautomerism in RNA biology and in the generation of spontaneous mutations during DNA replication. We will also discuss the role of tautomerism in the development of nucleoside/nucleotide analogs based antiviral therapeutics. Specifically, we will focus on tautomerism in the catalysis of small self-cleaving ribozymes and in ligands recognition by riboswitches. We will discuss evidence of tautomerism in DNA and the associated mechanisms that contribute to the generation of spontaneous mutations. We will also review the role of tautomerism in the mechanism by which antiviral drug candidates based on nucleoside analogs, such as molnupiravir (isopropyl ester prodrug of the ribonucleoside analog &#x3b2;-D-N<sup>4</sup>-hydroxycytidine) and KP1212 (5-aza-5,6-dihydro-2&#x2032;-deoxycytidine), induce lethal mutagenesis in the genomes of SARS-CoV-2 and HIV, respectively. Minor tautomers are rare and their dynamics of interconversion is fast, which makes them challenging to identify in complex macromolecular systems, such as DNA and RNA. In the last section, we will summarize the current, state-of-the-art methods for studying tautomerism in nucleic acids and in antiviral nucleoside analogs, and discuss the future directions of the&#x20;field.</p>
<sec id="s1-1">
<title>Tautomerism in Nucleic Acids</title>
<p>Nucleic acids display keto-enol and amino-imino types of tautomerism (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>), as shown in <xref ref-type="fig" rid="F1">Figure&#x20;1</xref> using cytosine as an example. This type of tautomerism, called prototropic tautomerism (<xref ref-type="bibr" rid="B31">Laar, 1886</xref>; <xref ref-type="bibr" rid="B4">Antonov, 2013</xref>) involves the movement of protons in the form of deprotonation at one site and protonation at another site, which is accompanied by a rearrangement of the double bonds in between the two sites. The base pairing complementarity in nucleic acids depends on the position of protons on the Watson-Crick (W-C) interface (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>). As the positions of protons change between different tautomers (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>) (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>), the distribution of hydrogen donor and acceptor sites is altered on the W-C face of each base. Therefore, certain minor tautomeric forms of canonical nucleic acid bases can engage in alternative base pairings (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). Since base pairing interactions are predominantly responsible for the biological functions performed by nucleic acids, prototropic tautomerism is expected to influence the biology of both DNA and RNA (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). Below we discuss a few notable examples where nucleobase tautomerism is a key contributor or otherwise modulates the biological functions performed by nucleic&#x20;acids.</p>
<sec id="s1-1-1">
<title>Tautomerism in RNA Riboswitches</title>
<p>The ligand recognition by the purine and thiamine pyrophosphate riboswitches involves binding to minor tautomeric forms of their non-natural ligands (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>) (<xref ref-type="bibr" rid="B61">Thore et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). The purine riboswitch regulates expression of genes involved in the metabolism of adenine and guanine. The regulation is mediated by the conformational change in response to binding to purine ligands (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B20">Gilbert et&#x20;al., 2006</xref>). In addition to recognizing adenine and guanine, the purine riboswitch can also bind to metabolites of purines such as xanthine, hypoxanthine and 2,6-diaminopurine (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B20">Gilbert et&#x20;al., 2006</xref>). Crystal structures of these ligands bound to the purine riboswitch show that the cytosine at the 74 position (C74) is critical for determining substrate specificity (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>) (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>). The carbonyl oxygen (O2) of C74 and U51 form hydrogen bonds with the 2-amino functional group of the native ligand guanine (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>), which explain the riboswitch preference for ligands that have a hydrogen bond donor at the 2-position of purines such as guanine and 2,6-diaminopurine (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B20">Gilbert et&#x20;al., 2006</xref>). However, the riboswitch can also bind to xanthine, which has a carbonyl group at the 2-position, and hypoxanthine, which lacks any functional group at that positon, albeit with a weaker affinity (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>) (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>). Xanthine binding has a dissociation constant (K<sub>D</sub>) of 32&#xa0;&#x3bc;M, three orders of magnitude higher than the nanomolar K<sub>D</sub>s for guanine and 2,6-diaminopurine (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>). Hypoxanthine has 200-fold less affinity compared to guanine (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>). However, the crystal structures of the riboswitch bound to xanthine or guanine ligands reveal no significant structural differences (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>). To rationalize their identical structures, it was proposed that the 2-enol form of xanthine would alleviate the repulsive interactions that exist due to the presence of three negatively charged oxygens in close proximity (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>) (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). This proposal was also consistent with the biochemical observation that xanthine binds the riboswitch at a pH of 6 (K<sub>D</sub> &#x3d; 33&#xa0;&#xb5;M), but no binding is detected at a higher pH of 8.5 (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>). The enol tautomers are expected to be more stable at lower pH (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>). Despite the observed crystallographic and biochemical evidence in support of the minor 2-enol tautomer, the direct existence of 2-enol xanthine has not been established. This is due, in part, to the lack of sensitive methods for distinguishing keto and enol forms of xanthine in the background overlapping signals from polymeric RNA (<xref ref-type="bibr" rid="B21">Gilbert et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>).</p>
<p>Tautomerism is also suggested to influence oxythiamine pyrophosphate (OxyTPP) binding to the thiamine pyrophosphate (TPP) riboswitch (<xref ref-type="bibr" rid="B62">Thore et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B61">Thore et&#x20;al., 2008</xref>). The TPP riboswitch binds to its natural ligand, TPP, to negatively regulate the expression of genes involved in the biosynthesis and transport of thiamine (<xref ref-type="bibr" rid="B62">Thore et&#x20;al., 2006</xref>). The X-ray structure of the riboswitch with the TPP ligand shows that the amino group at the 4&#x2032;-position of TPP acts as a hydrogen bond donor to the N3 position of G28 (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>) (<xref ref-type="bibr" rid="B62">Thore et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B61">Thore et&#x20;al., 2008</xref>). The OxyTPP has a carbonyl group at the 4&#x2032;-position. Yet, under crystalline conditions, its hydrogen bonding interactions to G28 are almost identical to those of TPP (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>) (<xref ref-type="bibr" rid="B61">Thore et&#x20;al., 2008</xref>). The 4&#x2032;- position of OxyTPP can only act as a hydrogen bond donor in its enol form, leading to the hypothesis that OxyTPP binds to the riboswitch as an enol tautomer (<xref ref-type="bibr" rid="B61">Thore et&#x20;al., 2008</xref>). The Oxythiamine (Oxy) portion of OxyTPP exists in three tautomeric forms including the proposed 4&#x2032;-enol tautomer (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). Biochemical binding isotope effect (BIE) experiments combined with density functional theory (DFT) calculations performed using O-18 labelled OxyTPP could not unambiguously identify the tautomer of OxyTPP in the binding pocket of the TPP riboswitch (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). More sensitive methods, such as NMR relaxation dispersion, low temperature NMR, FTIR (Fourier Transform Infrared Spectroscopy) and 2D-IR (2-Dimentional Infrared Spectroscopy) (discussed in the Methods overview) are needed to unambiguously characterize the tautomeric form of OxyTPP or its binding partner G28 on the TPP riboswitch.</p>
</sec>
<sec id="s1-1-2">
<title>Tautomerism in Self-Cleaving Ribozymes</title>
<p>Small self-cleaving ribozymes are proposed to utilize the minor tautomeric form(s) of catalytic guanosines to execute the first step of the self-cleavage reactions (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>) (<xref ref-type="bibr" rid="B10">Cochrane and Strobel, 2008a</xref>). As mentioned above, the hammerhead, hairpin, glmS, VS, HDV, and the twister ribozymes are examples of small self-cleaving ribozymes that catalyze the nucleolytic intramolecular self-scission reactions (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>) (reviewed in (<xref ref-type="bibr" rid="B10">Cochrane and Strobel, 2008a</xref>)). Their reaction mechanism are very similar, and they typically involve base catalyzed activation of the site-specific 2&#x2032;-hydroxyl that acts as a nucleophile to attack the adjacent scissile 3&#x2032;-phosphate. This reaction yields two RNA products: one containing the 2&#x2032;,3&#x2032;-cyclic phosphate and the other the 5&#x2032;-hydroxyl functional group (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). The only exception to this mechanism is the <italic>glmS</italic> ribozyme, which requires an external cofactor in the self-cleavage reaction (<xref ref-type="bibr" rid="B9">Cochrane et&#x20;al., 2007</xref>).</p>
<p>The self-scission reactions catalyzed by these ribozymes are proposed to utilize the minor tautomeric form of catalytic guanosines, in which the N1 is not protonated, to act as a general base in the 2&#x2032;-hydroxyl activation step of the reaction (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>) (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Structural studies of hammerhead (<xref ref-type="bibr" rid="B37">Martick and Scott, 2006</xref>), hairpin (<xref ref-type="bibr" rid="B52">Rupert and Ferr&#xe9;-D&#x27;Amar&#xe9;, 2001</xref>), VS (<xref ref-type="bibr" rid="B58">Suslov et&#x20;al., 2015</xref>) and the glmS (<xref ref-type="bibr" rid="B9">Cochrane et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B29">Klein and Ferre&#x301;-D&#x27;Amare&#x301;, 2006</xref>) ribozymes identified the N1 of catalytic guanosines in close proximity, within hydrogen bonding distance, to the 2&#x2032;-hydroxyl nucleophile. These studies established that the N1 of G33 in <italic>glmS</italic> (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>) (<xref ref-type="bibr" rid="B9">Cochrane et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B29">Klein and Ferre&#x301;-D&#x27;Amare&#x301;, 2006</xref>), G8 in hairpin (<xref ref-type="fig" rid="F3">Figure&#x20;3C</xref>) (<xref ref-type="bibr" rid="B19">Fedor, 2000</xref>; <xref ref-type="bibr" rid="B48">Pinard et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B52">Rupert and Ferr&#xe9;-D&#x27;Amar&#xe9;, 2001</xref>; <xref ref-type="bibr" rid="B30">Kuzmin et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B7">Bevilacqua and Yajima, 2006</xref>), G12 in hammerhead (<xref ref-type="fig" rid="F3">Figure&#x20;3D</xref>) (<xref ref-type="bibr" rid="B38">McKay, 1996</xref>; <xref ref-type="bibr" rid="B23">Han and Burke, 2005</xref>; <xref ref-type="bibr" rid="B37">Martick and Scott, 2006</xref>; <xref ref-type="bibr" rid="B60">Thomas and Perrin, 2008</xref>), and G638 in VS (<xref ref-type="fig" rid="F3">Figure&#x20;3E</xref>) (<xref ref-type="bibr" rid="B32">Lafontaine et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B25">Hiley et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B57">Sood and Collins, 2002</xref>; <xref ref-type="bibr" rid="B58">Suslov et&#x20;al., 2015</xref>) play the role of a general base in the self-cleavage reactions catalyzed by these ribozymes.</p>
<p>However, the N1 of guanosine has a p<italic>K</italic>
<sub>a</sub> of &#x223c;10 and is protonated at the physiological pH of &#x223c;7.4 (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). The protonated N1 of guanosine is a poor base to abstract a proton from the 2&#x2032;-hydroxyl, which has a p<italic>K</italic>
<sub>a</sub> of &#x223c;13 (<xref ref-type="bibr" rid="B64">Velikyan et&#x20;al., 2001</xref>). Therefore, tautomeric or ionic forms of the catalytic guanosines in which the N1 is not protonated are expected to form transiently during the catalysis. These minor tautomers are likely more nucleophilic at N1, and thus could extract the proton from the 2&#x2032;-hydroxyl groups (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). Generation of N1 unprotonated guanosine would require perturbation of its p<italic>K</italic>
<sub>a</sub> towards neutrality. Significant perturbations in p<italic>K</italic>
<sub>
<italic>a</italic>
</sub>, by as much as four units, have been reported in RNA systems, including ribozymes and riboswitches (<xref ref-type="bibr" rid="B33">Legault and Pardi, 1997</xref>; <xref ref-type="bibr" rid="B67">Wilcox and Bevilacqua, 2013</xref>). Perturbation of p<italic>K</italic>
<sub>a</sub> towards neutrality would facilitate deprotonation at the N1 site of catalytic guanosines because prototropic tautomerism involves the deprotonation and the protonation steps, and is optimal in functional groups whose p<italic>K</italic>
<sub>a</sub>&#x2019;s are close to neutral (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>).</p>
<p>Despite significant structural and biochemical evidence in support for the presence minor tautomeric forms of catalytic guanosines in small self-cleaving ribozymes, their direct identification has proven challenging, owing to the lack of sensitive methods (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>).</p>
</sec>
<sec id="s1-1-3">
<title>Tautomerism in DNA and its Role in Replication Fidelity</title>
<p>The genetic integrity of genomic DNA relies on adenine, guanine, cytosine and thymine existing predominantly in their keto and amino tautomeric forms during replication and transcription (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). Therefore, replication fidelity is expected to be influenced by the formation of minor tautomers (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). In their work on the structure of DNA, Watson and Crick did appreciate that the formation of minor tautomeric forms would alter the base pairing properties of nucleic acid bases, potentially with mutagenic consequences (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>). These minor tautomeric forms could arise from inter-helical transfer of protons in a DNA duplex (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>) (<xref ref-type="bibr" rid="B35">L&#xf6;wdin, 1963</xref>; <xref ref-type="bibr" rid="B53">Sevilla et&#x20;al., 1995</xref>). Transient formation of minor tautomeric forms of DNA bases, and their stabilization in the active site of DNA polymerases during replication, could lead to incorporation of mismatched base pairs (<xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>). This phenomenon is plausible considering that the kinetics of minor tautomer formation and their lifetime in the active site is comparable with the kinetics of nucleotide incorporation by the polymerase. Therefore, the probability of base misincorporation during DNA replication may be correlated with the probability of rare tautomer formation (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>) (<xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>).</p>
<p>Structural evidence for the rare tautomer hypothesis for spontaneous mutation came from the high-resolution crystal structure of a DNA polymerase that catalyzes replication in crystals (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>) (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>). It was observed that a C&#x2022;A mismatch mimics the shape of the cognate C&#x2022;G base pair in the crystal (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>). The movement of protons in the mismatched bases alter the hydrogen-bonding pattern such that the base pairs involving the minor tautomeric forms adopt an overall shape that is virtually indistinguishable from the canonical W-C base pair in DNA (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>). This &#x201c;shape mimicry&#x201d; allows the mismatch to evade error detection mechanisms of human polymerases (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). These observations provided structural support for the rare tautomer hypothesis of spontaneous mutagenesis.</p>
<p>NMR dispersion methods have allowed us to gain better understanding of tautomeric dynamics in DNA, and in RNA duplexes (<xref ref-type="bibr" rid="B27">Kimsey et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). Using W-C mismatches such as G-T or G-U, these studies established that G&#x2022;T/U wobble mismatches exist in dynamic equilibrium between three distinct W-C mismatched base pairs within the DNA and RNA duplexes (<xref ref-type="bibr" rid="B27">Kimsey et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). The three distinct W-C mismatches include two tautomeric and one anionic species (<xref ref-type="bibr" rid="B27">Kimsey et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). The tautomeric forms were established using the chemical shifts of guanine N1 and thymidine/uridine N3. The chemical shifts, although consistent with G<sup>enol</sup>&#x2022;T/U base pair (minor enol tautomer of G paired with the dominant keto tautomeric form of T or U) were partially skewed toward G&#x2022;T<sup>enol</sup>/U<sup>enol</sup> pairs (keto-amino tautomer of G paired with enol tautomer of T or U) (<xref ref-type="bibr" rid="B27">Kimsey et&#x20;al., 2018</xref>). This skewness was interpreted as evidence for a rapid equilibrium between the major G<sup>enol</sup>&#x2022;T/U and the minor G&#x2022;T<sup>enol</sup>/U<sup>enol</sup> tautomeric base pairs (<xref ref-type="bibr" rid="B27">Kimsey et&#x20;al., 2018</xref>). The two rapidly exchanging tautomeric species (G<sup>enol</sup>&#x2022;T/U&#x21cc;G&#x2022;T<sup>enol</sup>/U<sup>enol</sup>) were also quantitated and found to be around 0.4% of the total population at neutral pH. Increased understanding of base pairing mismatches like G&#x2022;T, G&#x2022;U, and A&#x2022;C that nevertheless adopt W-C like geometry through either tautomerization or ionization allowed us to appreciate that these mismatches appear to be more common (<xref ref-type="bibr" rid="B27">Kimsey et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). Stabilization of W-C mismatches through tautomerization, either in the template strand or in the incoming nucleotide, could allow the incorporation of mismatches during replication (<xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>), and remains a compelling mechanistic explanation for spontaneous mutagenesis.</p>
</sec>
</sec>
<sec id="s1-2">
<title>Therapeutic Implications of Tautomeric Nucleosides</title>
<p>Nucleoside/nucleotide analogs enriched in minor tautomers are effective as antiviral agents against many viruses (<xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B5">Baranovich et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B14">Delang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). The antiviral property of these analogs stem from their ability to induce mutations in viral genomes (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B14">Delang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B22">Gordon et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). Such nucleoside analogs are mutagenic, in part, because they form significant amounts of minor tautomeric forms, which enables them to engage in ambiguous base pairing, i.e.,&#x20;paring with more than one base (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B14">Delang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). The concept of specifically increasing the mutation rates of pathogens to drive their population collapse is particularly effective against retroviruses and riboviruses (<xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B3">Anderson et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B15">Domingo et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B36">Manrubia et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B16">Domingo et&#x20;al., 2012</xref>). These viruses have high mutation rates and their population lives close to the mutational threshold called the error catastrophe limit (ECL), a theoretical mutational rate above which producing viable viral progeny becomes impossible and leads to viral population collapse (<xref ref-type="bibr" rid="B17">Eigen, 2002</xref>). This phenomenon is called lethal mutagenesis. Additionally, unlike the human replicative polymerases that feature both high selectivity and high fidelity, the replication machinery of retroviruses is both promiscuous and error prone and thus, it can readily incorporate mutagenic nucleoside analogs (<xref ref-type="bibr" rid="B3">Anderson et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). Therefore, these nucleoside analogs selectively mutagenize the viral genomes, while leaving the host (human) genome essentially untouched (<xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B3">Anderson et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B14">Delang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>).</p>
<p>Nucleoside analogs that induce lethal mutagenesis are effective as antiviral drugs against many retroviruses and riboviruses, such as HIV, HCV, influenza virus and coronaviruses (<xref ref-type="bibr" rid="B3">Anderson et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B5">Baranovich et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B14">Delang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B22">Gordon et&#x20;al., 2021</xref> <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). These viruses have high mutation rates and their replication machinery is error-prone (<xref ref-type="bibr" rid="B66">Watson and Crick, 1953</xref>; <xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). The error prone nature of some viral polymerases allows incorporation of modified nucleosides (<xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). The 5-aza-5,6-dihydro-2&#x2032;-deoxycytidine (KP1212) is an experimental drug candidate that targets HIV by increasing the mutation rate of the virus (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>) (<xref ref-type="bibr" rid="B24">Harris et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B42">Mullins et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). The antiviral efficacy of KP1212 stems from its ability to exist in multiple tautomeric states (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). These tautomers can engage in ambiguous base pairings to induce mutagenesis in HIV (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). Other antiviral drugs such as ribavirin for HCV (<xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>), and favipiravir for influenza (<xref ref-type="bibr" rid="B5">Baranovich et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B14">Delang et&#x20;al., 2018</xref>) are also efficacious due, in part, to their ability to exist in multiple tautomeric or rotameric forms and induce mutagenesis in viral genomes. Lethal mutagenesis has also been implicated as the main mechanism of action for the recently developed small-molecule therapeutics, such as molnupiravir from Merck, for severe acute respiratory syndrome coronavirus (SARS-CoV-2, the virus that causes Covid-19) (<xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B69">Zhou, 2021</xref>).</p>
<p>The mechanism by which KP1212 induces lethal mutagenesis in HIV has been studied extensively (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). KP1212 is mutagenic, inducing G to A and A to G transition mutations (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>) (<xref ref-type="bibr" rid="B24">Harris et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). The mutagenicity of KP1212 is due, in part, to its ability to exist in multiple tautomeric or rotameric forms (<xref ref-type="bibr" rid="B44">Peng et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). While KP1212 is considered a dC (deoxycytidine) analog, because it features the functional groups and the W-C face of dC, it has a near neutral pKa of &#x223c;7, compared to p<italic>K</italic>
<sub>a</sub> of &#x223c;4 for dC. As a consequence, KP1212 in solution exists in multiple tautomeric states (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). These include keto-amino, keto-imino and its rotameric form, enol-amino and enol-imino and its rotameric form (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). The enol-amino and enol-imino are the dominant tautomeric forms of KP1212, in contrast to the dominant keto-amino form observed for dC (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). The alternative tautomeric forms of KP1212 are expected to have perturbed base pairing properties (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>), and thus contribute to the mutagenic properties of the base. KP1212 was shown to induce G to A and A to G mutations in the HIV genomes in cellular models, in preclinical rodents studies and in HIV patients who participated in the clinical trials for KP1212 (<xref ref-type="bibr" rid="B24">Harris et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B42">Mullins et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). However, these studies also revealed that KP1212 is not mutagenic to human cells. Lack of mutagenicity in humans is likely due to the higher fidelity and selectivity of human DNA replicative polymerases (<xref ref-type="bibr" rid="B42">Mullins et&#x20;al., 2011</xref>). Unlike dC, KP1212 has a saturated carbon center at the 6-position, which causes the base ring to be puckered (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). This geometric distortion is significant enough to be selected against by the human polymerases. KP1212, therefore, exemplifies the features of an ideal lethal mutagen because it specifically induces mutations in HIV, driving viral population collapse, while sparing the human genome.</p>
<p>Molnupiravir is a broad-spectrum nucleoside analog drug that is efficacious against many viruses including the proofreading-intact SARS-CoV-2 coronavirus with a high genetic barrier to resistance (<xref ref-type="bibr" rid="B22">Gordon et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B1">Agostini et&#x20;al., 2019</xref>). Its efficacy stems from its ability to induce lethal mutagenesis in SARS-CoV-2, during the early stages of Covid-19 (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>) (<xref ref-type="bibr" rid="B1">Agostini et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B22">Gordon et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B39">Men&#xe9;ndez-Arias, 2021</xref>). Molnupiravir is an isopropyl ester prodrug of the ribonucleoside analog &#x3b2;-D-N<sup>4</sup>-hydroxycytidine (NHC) (<xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). It is currently in the phase-III clinical trial for Covid-19 (<xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). Biochemical studies using SARS-CoV-2 RNA-dependent-RNA polymerase (SARS-CoV-2 RdRp) have shown that the triphosphate form of NHC can be incorporated into RNA, albeit at a lower frequency compared to canonical nucleosides (<xref ref-type="bibr" rid="B22">Gordon et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B39">Men&#xe9;ndez-Arias, 2021</xref>). Once incorporated into the growing strand, it can be extended at its 3&#x2032;-end. When present in the template strand it can form base pairs with G (NHC:G) or A (NHC:A) to induce G to A or A to G mutations (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>) (<xref ref-type="bibr" rid="B22">Gordon et&#x20;al., 2021</xref>). The NHC:A base pairs is more efficiently extended compared to NHC:G (<xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). Cellular studies have shown that NHC is 100-fold more active than ribavirin and favipiravir against SARS-CoV-2 (<xref ref-type="bibr" rid="B69">Zhou, 2021</xref>). The higher activity molnupiravir also induces a higher mutation frequency in the viral RNA (<xref ref-type="bibr" rid="B39">Men&#xe9;ndez-Arias, 2021</xref>; <xref ref-type="bibr" rid="B69">Zhou, 2021</xref>). Structural analysis of RdRp&#x2013;RNA complexes containing mutagenesis products revealed that the NHC moiety can form stable base pairs with either G or A in the active site of RdRp (<xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). The formation of stable base mispairs with G or A, in W-C conformations, allow molnupiravir to escape the proofreading mechanism of the SARS-CoV-2 RdRp polymerase (<xref ref-type="bibr" rid="B1">Agostini et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B22">Gordon et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B39">Men&#xe9;ndez-Arias, 2021</xref>). The accumulation of mutations with each round of viral multiplication would lead to weakening of the virus (<xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B39">Men&#xe9;ndez-Arias, 2021</xref>). Similar to molnupiravir against SARS-CoV-2, ribavirin and favipiravir target HCV, and influenza, respectively, in part by the lethal mutagenesis mechanism (<xref ref-type="bibr" rid="B13">Crotty et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B5">Baranovich et&#x20;al., 2013</xref>). Taken together, all the above studies underscore the importance of better understanding the mechanisms by which nucleoside analogs are incorporated and lead to mispaired bases in viral genomes.</p>
</sec>
<sec id="s1-3">
<title>Methods for Studying Tautomerism in Nucleic Acids and in Nucleoside Analogs</title>
<p>Minor tautomers of canonical nucleic acid bases and their analogs are rare, transient, and interconvert on a fast time scale (<xref ref-type="bibr" rid="B63">Topal and Fresco, 1976</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). Recent developments of spectroscopic methods have allowed their direct identification in nucleic acids and in nucleoside analogs (<xref ref-type="fig" rid="F6">Figure&#x20;6</xref>) (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B47">Peng and Tokmakoff, 2012</xref>; <xref ref-type="bibr" rid="B44">Peng et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B59">Szymanski et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). Prototropic tautomers differ from one another based on the position of protons, and the position of double bonds. Therefore, methods that are capable of detecting and distinguishing protons in different chemical environment (for example, NMR) are useful for the direct identification of tautomeric forms (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B44">Peng et&#x20;al., 2013</xref>) in both nucleic acids and nucleoside analogs (<xref ref-type="fig" rid="F6">Figures 6B,C</xref>) (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). Similarly, methods that provide information on the bond order and strength of a specific chemical bond (such as IR and Raman spectroscopy) are useful for distinguishing between keto-enol or amino-imino tautomeric forms, because the functional groups in each tautomeric pair have very different and characteristic vibrational properties. In addition, biochemical binding isotope effects and their interpretation using computational DFT have been used for characterizing tautomeric forms of a ligand in the binding pocket of an RNA aptamer (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>) (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Methods for studying tautomerism in nucleoside analogs and nucleic acids. <bold>(A)</bold> Left side: The Fourier-Transform Infrared (FTIR) spectra for 2&#x2032;-deoxycytidine (dC) at room temperature, and the temperature dependence of vibrational frequencies in the. FTIR spectra for KP1212. Right side: The 2-Dimensional Infrared (2D-IR) spectroscopic data for KP1212, in aqueous solution at room temperature (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). <bold>(B)</bold> Variable temperature 1H-NMR data for KP1212 (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). <xref ref-type="fig" rid="F6">Figures 6A,B</xref> are adapted from (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). <bold>(C)</bold> Binding isotope effects combined with Density Functional theory (DFT) calculations used in the characterization of the tautomeric form of OxyTPP bound to the TPP riboswitch (<xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). Reprinted (adapted) with permission from (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>) <italic>Copyright &#xa9; 2014, American Chemical Society.</italic> <bold>(D)</bold> NMR relaxation dispersion methods used to identify and quantitate rare tautomers in a G&#x2022;T mismatch in DNA/RNA duplexes in W-C conformations (<xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>). Figure courtesy of Hashim Al-Hashimi Duke University.</p>
</caption>
<graphic xlink:href="fmolb-08-823253-g006.tif"/>
</fig>
<p>NMR measures the chemical shift of individual protons, a property that depends on the chemical environment of the proton. Since the protons in tautomeric pairs are attached to different heteroatoms, their NMR chemical shifts are very different and thus distinguishable. Often, because the tautomeric equilibria are faster than the NMR acquisition time scale, broader peaks are observed, that span areas of multiple tautomeric forms. However, by substantially lowering the temperature of the sample (a method called variable temperature NMR), the tautomeric equilibria can be slowed down sufficiently to resolve the individual tautomeric&#x20;forms.</p>
<p>Infrared spectroscopy (IR) measures the vibrational properties of the chemical bonds. Depending on their chemical makeup and bond order, different bonds absorb infrared radiation at different wavelengths. IR spectra provide direct information on the types of bonds present in a molecule, and therefore can easily distinguish between keto-enol or amino-imino tautomeric forms. Two-dimensional IR (2D-IR), an advanced version of IR, uses the same principle but provides, in addition, information on bond connectivity. Bonds in the same molecule vibrate together, and thus give a characteristic cross peak in the spectrum, which allows the distinction between the individual tautomeric forms present at equilibrium.</p>
<p>In addition to the direct detection of rare tautomers in nucleic acids, which is very challenging, indirect approaches, based on binding isotope effects (BIEs), exist that allow inference of minor tautomer formation. Theoretically, BIEs report on changes in vibrational frequencies of a ligand upon binding to its target. Experimentally, they are estimated using the binding affinities of ligands carrying either light or heavy isotopes of atoms directly involved in the binding interaction. The experimental BIEs are then compared to BIEs calculated, using the Density Functional Theory (DFT), from frequencies of optimized tautomeric forms. The exact characterization is completed by identifying a tautomeric structure whose calculated BIEs closely match the experimental BIEs. A good example of this approach is the identification of tautomeric form of OxyTPP recognized by the TPP riboswitch (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>), where spectroscopic observations indicated that each tautomer has a unique vibrational frequency pattern. This approach was used to study OxyTPP bound to the TPP riboswitch (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>), using <sup>18</sup>O and <sup>32</sup>P/<sup>33</sup>P labeled OxyTPP (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B55">Singh et&#x20;al., 2015</xref>). Although the calculated BIEs are different for the keto and enol forms of OxyTPP, the magnitude of the difference between the BIEs corresponding to various tautomers of OxyTPP was too small to yield a definite conclusion. More precise measurements of BIEs are nevertheless expected to provide clarity on the tautomeric form of OxyTPP bound to the TPP riboswitch (<xref ref-type="bibr" rid="B57">Sood and Collins, 2002</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). These studies also underscore the potential of indirect measurements like BIEs and kinetic isotope effects (KIEs) to increase our understanding of tautomerism in nucleic acids and base analogs.</p>
<p>The variable temperature NMR, FT-IR (Fourier Transform Infrared) and 2D-IR (2-dimensional Infrared) methods were used to identify the tautomers of KP1212 and oxythiamine (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). Tautomeric dynamics of these nucleoside analogs are fast, typically on the nanosecond timescale (<xref ref-type="bibr" rid="B44">Peng et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). Therefore, attempts to distinguish between the multiple tautomers of KP1212 at room temperature using NMR were not successful. Lowering the temperature to &#x2212;20&#xb0;C allowed identification of individual tautomers of KP1212 and oxythiamine by 1-dimentional proton NMR (<sup>1</sup>H-NMR) in the dimethylformamide (DMF) solvent (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>) (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). While the characterization and distribution of tautomers of KP1212 and oxythiamine by <sup>1</sup>H-NMR utilized non-physiological conditions with low temperature and an aprotic solvent (DMF) (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>), these experiments clearly outlined the chemical plausibility of the tautomeric forms of these compounds. For detecting multiple tautomers under physiologically relevant aqueous conditions at room temperature, IR-based methods have proven to be more effective (<xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). The temperature dependence of change in amplitude of vibrational frequencies in the 1D-FTIR spectrum confirmed the presence of multiple tautomers for KP1212 and oxythiamine (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>) (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>). To directly identify minor tautomers based on altered vibrational frequency of minor tautomers, 2D-IR data was combined with DFT calculations (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>) (<xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). The 2D IR spectrum has a greater spatial and temporal resolution than FTIR, and thus allows direct identification of multiple fast interconverting tautomers (<xref ref-type="bibr" rid="B44">Peng et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). These studies established that KP1212 exists in seven different tautomeric or rotameric forms and oxythiamine exists in three different tautomeric forms (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B56">Singh et&#x20;al., 2014</xref>). Furthermore, the biochemical observations that KP1212 is 10% mutagenic when replicated <italic>in&#x20;vitro</italic> and in living cells, and induces G to A mutations, can be rationalized by the tautomeric distribution identified from these spectroscopic studies (<xref ref-type="bibr" rid="B34">Li et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>).</p>
<p>By contrast with the nucleoside analogs described above, the minor tautomers of the canonical DNA bases are significantly less abundant, shorter lived and more challenging to detect (<xref ref-type="bibr" rid="B44">Peng et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B45">Peng et&#x20;al., 2015</xref>). NMR relaxation dispersion (RD) methods allow identification of low-abundance short-lived conformational states in biomolecules (<xref ref-type="fig" rid="F6">Figure&#x20;6D</xref>) (<xref ref-type="bibr" rid="B41">Mulder et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). NMR relaxation dispersion (RD) has been used to characterize rare tautomers in Hoogsteen base pairs versus Watson-Crick base pairs in different types of DNA/RNA, such as A or B type of DNA/RNA (<xref ref-type="bibr" rid="B43">Nikolova et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B2">Alvey et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B68">Zhou et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B50">Rangadurai et&#x20;al., 2018</xref>). These results offer understandings into differences between A-RNA and B-DNA duplexes and provide possible explanations for how they respond to damage and modifications.</p>
<p>Using NMR RD, it has been shown that the G&#x2022;T/U mismatches exist in dynamic equilibrium between tautomeric and anionic W-C conformations within the DNA and RNA duplexes. These studies also provided insights into the kinetics of rare tautomer formation in nucleic acids, and the probability of base misincorporation due to the formation of minor tautomers (<xref ref-type="bibr" rid="B51">Rangadurai et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Rangadurai et&#x20;al., 2020</xref>). These methods continue to enhance our understanding of the mechanisms by which the formation of minor tautomers contribute to the generation of spontaneous mutations.</p>
<p>Structural methods based on X-ray crystallography and Cryo-EM (Cryogenic electron microscopy) have proven effective in studying mismatched base pairs that potentially involve minor tautomers. While protons are very difficult to visualize directly by X-ray crystallography and Cryo-EM, the overall geometry of base pairs and the inter-heteroatom distances can be accurately measured, and thus allow to infer the presence of protons and hydrogen bonding interactions. Specifically, crystallographic studies have shown that mismatches in high fidelity DNA polymerases can adopt structures that closely mimic the W-C base pairing geometry (<xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). The existence of mismatches in conformations that are identical to W-C shapes may allow them to evade the polymerase proof reading mechanisms and lead to mutagenesis (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>, <xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>) (<xref ref-type="bibr" rid="B6">Bebenek et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B65">Wang et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B18">Fedeles et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Kabinger et&#x20;al., 2021</xref>). In sum, these studies have provided convincing structural evidence in support of rare tautomer hypothesis for the generation of spontaneous mutations that arise during nucleic acid replication.</p>
</sec>
</sec>
<sec id="s2">
<title>Future Directions</title>
<p>The last decade has seen significant progress in our understanding of tautomerism in DNA and RNA. Despite the early realization that tautomerism could influence nucleic acid biology, directly identifying rare tautomers of nucleic acid bases proved very challenging. The minor tautomers of DNA bases are present at equilibrium in minute amounts (&#x3c; 0.1%) and their dynamics of interconversion is generally very fast. Until recently, little progress was made in directly visualizing minor tautomers of DNA bases. The NMR RD allowed direct detection of rare tautomers and characterized the dynamics of their formation in short DNA sequences. Structurally establishing that mismatches can be stabilized in W-C conformation by high fidelity DNA polymerases, provided crystallographic support for the rare tautomer hypothesis of spontaneous mutations. Advancement in methods based on BIEs, high-resolution crystallography, NMR and IR significantly enhanced our mechanistic understanding of mutagenesis from nucleoside analogs based antiviral drugs. While all these advancements are notable, they only reflect special cases of tautomerism in a limited set of experimental conditions. Much work remains to develop more broadly applicable methods that enable the direct visualization and identification of minor tautomers of canonical bases in complex biological systems, such as genomic DNA, and in the binding pocket of polymerases, under physiological conditions. Sensitivity improvements in all the methods summarized above are all expected to improve our understanding of tautomerism. In the case of BIEs, more precise measurements are expected to help identify minor tautomers in the context of RNA systems and may provide further insights into the role of tautomerism in RNA biology, including catalytic processes and ribozymes. More work is also needed to bridge the knowledge gap between the in-solution tautomeric equilibria and dynamics of nucleobases and analogs, and their biological consequences. In the case of antiviral nucleoside analogs, such as KP1212 and molnupiravir, there is great interest to understand how tautomeric equilibria translate into mutagenic potential inside the viral polymerases. These nucleoside analogs have already proven very effective as antiviral drugs. However, our understanding of the physico-chemical properties that enable these compounds to adopt multiple tautomeric forms is still limited. Further insight into tautomeric equilibria and dynamics should allow us to develop more potent and safer antiviral therapeutics.</p>
</sec>
</body>
<back>
<sec id="s3">
<title>Author Contributions</title>
<p>All the authors made substantial, direct, and intellectual contribution to the manuscript and approved it for publication.</p>
</sec>
<sec id="s4">
<title>Funding</title>
<p>BF is supported by NIH grants R01-CA080024, P30-ES002109, P42-ES027707 and T32-ES007020. DL is supported by R01-ES028865. VS is supported by Novartis Institute of Biomedical Research.</p>
</sec>
<sec sec-type="COI-statement" id="s5">
<title>Conflict of Interest</title>
<p>Declaration of interest DL is an author on the patent US9283242B2 (assigned to Massachusetts Institute of Technology), BF and VS are authors on the patent US9714265B2 (assigned to Massachusetts Institute of Technology). These patents describe two classes of mutagenic nucleoside analogs that can adopt multiple tautomeric forms and their potential uses as anti-viral therapeutics.</p>
</sec>
<sec sec-type="disclaimer" id="s6">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors thank Michael Romanowski of Novartis Institute of Biomedical Research (NIBR); Hashim Al-Hashimi of Duke University for the NMR dispersion figure (<xref ref-type="fig" rid="F6">Figure&#x20;6D</xref>), and Joe Piccirilli of University of Chicago for providing the Varkud ribozyme figure (<xref ref-type="fig" rid="F3">Figure&#x20;3E</xref>).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agostini</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Pruijssers</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Chappell</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Gribble</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Andres</surname>
<given-names>E. L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Small-Molecule Antiviral &#x3b2;-d-N 4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance</article-title>. <source>J.&#x20;Virol.</source> <volume>93</volume> (<issue>24</issue>), <fpage>e01348</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01348-19</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvey</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Gottardo</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>Nikolova</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Al-Hashimi</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Widespread Transient Hoogsteen Base Pairs in Canonical Duplex DNA with Variable Energetics</article-title>. <source>Nat. Commun.</source> <volume>5</volume> (<issue>1</issue>), <fpage>4786</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms5786</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Daifuku</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Loeb</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Viral Error Catastrophe by Mutagenic Nucleosides</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>58</volume>, <fpage>183</fpage>&#x2013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.58.030603.123649</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Antonov</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2013</year>). <source>Tautomerism: Methods and Theories</source>. <publisher-loc>Sofia, Bulgaria</publisher-loc>: <publisher-name>John Wiley &#x26; Sons</publisher-name>. </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baranovich</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S.-S.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marjuki</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Webby</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>R. G.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses <italic>In Vitro</italic>
</article-title>. <source>J.&#x20;Virol.</source> <volume>87</volume> (<issue>7</issue>), <fpage>3741</fpage>&#x2013;<lpage>3751</lpage>. <pub-id pub-id-type="doi">10.1128/jvi.02346-12</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bebenek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Kunkel</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Replication Infidelity via a Mismatch with Watson-Crick Geometry</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>108</volume> (<issue>5</issue>), <fpage>1862</fpage>&#x2013;<lpage>1867</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1012825108</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bevilacqua</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yajima</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Nucleobase Catalysis in Ribozyme Mechanism</article-title>. <source>Curr. Opin. Chem. Biol.</source> <volume>10</volume> (<issue>5</issue>), <fpage>455</fpage>&#x2013;<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbpa.2006.08.014</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Godfrey</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>McNaughton</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pierlot</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Tautomers of Cytosine by Microwave Spectroscopy</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>111</volume> (<issue>6</issue>), <fpage>2308</fpage>&#x2013;<lpage>2310</lpage>. <pub-id pub-id-type="doi">10.1021/ja00188a058</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cochrane</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Lipchock</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Strobel</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Structural Investigation of the GlmS Ribozyme Bound to its Catalytic Cofactor</article-title>. <source>Chem. Biol.</source> <volume>14</volume> (<issue>1</issue>), <fpage>97</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2006.12.005</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cochrane</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Strobel</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Catalytic Strategies of Self-Cleaving Ribozymes</article-title>. <source>Acc. Chem. Res.</source> <volume>41</volume> (<issue>8</issue>), <fpage>1027</fpage>&#x2013;<lpage>1035</lpage>. <pub-id pub-id-type="doi">10.1021/ar800050c</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cochrane</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Strobel</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Riboswitch Effectors as Protein Enzyme Cofactors</article-title>. <source>Rna</source> <volume>14</volume> (<issue>6</issue>), <fpage>993</fpage>&#x2013;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1261/rna.908408</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colominas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Luque</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Orozco</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Tautomerism and Protonation of Guanine and Cytosine. Implications in the Formation of Hydrogen-Bonded Complexes</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>118</volume> (<issue>29</issue>), <fpage>6811</fpage>&#x2013;<lpage>6821</lpage>. <pub-id pub-id-type="doi">10.1021/ja954293l</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crotty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cameron</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Andino</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>RNA Virus Error Catastrophe: Direct Molecular Test by Using Ribavirin</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>98</volume> (<issue>12</issue>), <fpage>6895</fpage>&#x2013;<lpage>6900</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.111085598</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Abdelnabi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Neyts</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Favipiravir as a Potential Countermeasure against Neglected and Emerging RNA Viruses</article-title>. <source>Antivir. Res.</source> <volume>153</volume>, <fpage>85</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.03.003</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domingo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Grande-P&#xe9;rez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mart&#xed;n</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Future Prospects for the Treatment of Rapidly Evolving Viral Pathogens: Insights from Evolutionary Biology</article-title>. <source>Expert Opin. Biol. Ther.</source> <volume>8</volume> (<issue>10</issue>), <fpage>1455</fpage>&#x2013;<lpage>1460</lpage>. <pub-id pub-id-type="doi">10.1517/14712598.8.10.1455</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domingo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sheldon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Perales</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Viral Quasispecies Evolution</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>76</volume> (<issue>2</issue>), <fpage>159</fpage>&#x2013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1128/mmbr.05023-11</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eigen</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Error Catastrophe and Antiviral Strategy</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>99</volume> (<issue>21</issue>), <fpage>13374</fpage>&#x2013;<lpage>13376</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.212514799</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fedeles</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Freudenthal</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Yau</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.-c.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Intrinsic Mutagenic Properties of 5-chlorocytosine: A Mechanistic Connection between Chronic Inflammation and Cancer</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>112</volume> (<issue>33</issue>), <fpage>E4571</fpage>&#x2013;<lpage>E4580</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1507709112</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fedor</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Structure and Function of the Hairpin Ribozyme</article-title>. <source>J.&#x20;Mol. Biol.</source> <volume>297</volume> (<issue>2</issue>), <fpage>269</fpage>&#x2013;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.2000.3560</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Mediatore</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Batey</surname>
<given-names>R. T.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Modified Pyrimidines Specifically Bind the Purine Riboswitch</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>128</volume> (<issue>44</issue>), <fpage>14214</fpage>&#x2013;<lpage>14215</lpage>. <pub-id pub-id-type="doi">10.1021/ja063645t</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Reyes</surname>
<given-names>F. E.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Batey</surname>
<given-names>R. T.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Adaptive Ligand Binding by the Purine Riboswitch in the Recognition of Guanine and Adenine Analogs</article-title>. <source>Structure</source> <volume>17</volume> (<issue>6</issue>), <fpage>857</fpage>&#x2013;<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2009.04.009</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Tchesnokov</surname>
<given-names>E. P.</given-names>
</name>
<name>
<surname>Schinazi</surname>
<given-names>R. F.</given-names>
</name>
<name>
<surname>G&#xf6;tte</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Molnupiravir Promotes SARS-CoV-2 Mutagenesis via the RNA Template</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>297</volume>, <fpage>100770</fpage>. <pub-id pub-id-type="doi">10.1016/j.jbc.2021.100770</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Model for General Acid&#x2212;Base Catalysis by the Hammerhead Ribozyme: pH&#x2212;Activity Relationships of G8 and G12 Variants at the Putative Active Site</article-title>. <source>Biochemistry</source> <volume>44</volume> (<issue>21</issue>), <fpage>7864</fpage>&#x2013;<lpage>7870</lpage>. <pub-id pub-id-type="doi">10.1021/bi047941z</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Brabant</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Styrchak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gall</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Daifuku</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>KP-1212/1461, a Nucleoside Designed for the Treatment of HIV by Viral Mutagenesis</article-title>. <source>Antivir. Res.</source> <volume>67</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2005.03.004</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiley</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Sood</surname>
<given-names>V. D.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>4-thio-U Cross-Linking Identifies the Active Site of the VS Ribozyme</article-title>. <source>Embo J</source> <volume>21</volume> (<issue>17</issue>), <fpage>4691</fpage>&#x2013;<lpage>4698</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdf462</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabinger</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stiller</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schmitzov&#xe1;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dienemann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kokic</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hillen</surname>
<given-names>H. S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Mechanism of Molnupiravir-Induced SARS-CoV-2 Mutagenesis</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>28</volume> (<issue>9</issue>), <fpage>740</fpage>&#x2013;<lpage>746</lpage>. <pub-id pub-id-type="doi">10.1038/s41594-021-00651-0</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimsey</surname>
<given-names>I. J.</given-names>
</name>
<name>
<surname>Szymanski</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Zahurancik</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Shakya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C.-C.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Dynamic Basis for dGdT Misincorporation via Tautomerization and Ionization</article-title>. <source>Nature</source> <volume>554</volume> (<issue>7691</issue>), <fpage>195</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1038/nature25487</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Been</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Ferr&#xe9;-D&#x27;Amar&#xe9;</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Essential Role of an Active-Site Guanine in glmS Ribozyme Catalysis</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>129</volume> (<issue>48</issue>), <fpage>14858</fpage>&#x2013;<lpage>14859</lpage>. <pub-id pub-id-type="doi">10.1021/ja0768441</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Ferre&#x301;-D&#x27;Amare&#x301;</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Structural Basis of glmS Ribozyme Activation by Glucosamine-6-Phosphate</article-title>. <source>Science</source> <volume>313</volume> (<issue>5794</issue>), <fpage>1752</fpage>&#x2013;<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1126/science.1129666</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuzmin</surname>
<given-names>Y. I.</given-names>
</name>
<name>
<surname>Da Costa</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Fedor</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Role of an Active Site Guanine in Hairpin Ribozyme Catalysis Probed by Exogenous Nucleobase rescue</article-title>. <source>J.&#x20;Mol. Biol.</source> <volume>340</volume> (<issue>2</issue>), <fpage>233</fpage>&#x2013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2004.04.067</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laar</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1886</year>). <article-title>Ueber die Hypothese der wechselnden Bindung</article-title>. <source>Ber. Dtsch. Chem. Ges.</source> <volume>19</volume> (<issue>1</issue>), <fpage>730</fpage>&#x2013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1002/cber.188601901165</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lafontaine</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Lilley</surname>
<given-names>D. M. J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The A730 Loop Is an Important Component of the Active Site of the VS Ribozyme 1&#x20;1Edited by J.&#x20;Karn</article-title>. <source>J.&#x20;Mol. Biol.</source> <volume>312</volume> (<issue>4</issue>), <fpage>663</fpage>&#x2013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.2001.4996</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Legault</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pardi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Unusual Dynamics and pKa Shift at the Active Site of a Lead-Dependent Ribozyme</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>119</volume> (<issue>28</issue>), <fpage>6621</fpage>&#x2013;<lpage>6628</lpage>. <pub-id pub-id-type="doi">10.1021/ja9640051</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fedeles</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Silvestre</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Simi</surname>
<given-names>A. K.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Tautomerism Provides a Molecular Explanation for the Mutagenic Properties of the Anti-HIV Nucleoside 5-Aza-5,6-Dihydro-2&#x27;-Deoxycytidine</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>111</volume> (<issue>32</issue>), <fpage>E3252</fpage>&#x2013;<lpage>E3259</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1405635111</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf6;wdin</surname>
<given-names>P.-O.</given-names>
</name>
</person-group> (<year>1963</year>). <article-title>Proton Tunneling in DNA and its Biological Implications</article-title>. <source>Rev. Mod. Phys.</source> <volume>35</volume> (<issue>3</issue>), <fpage>724</fpage>&#x2013;<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1103/revmodphys.35.724</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manrubia</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Domingo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>L&#xe1;zaro</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Pathways to Extinction: beyond the Error Threshold</article-title>. <source>Phil. Trans. R. Soc. B</source> <volume>365</volume> (<issue>1548</issue>), <fpage>1943</fpage>&#x2013;<lpage>1952</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2010.0076</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martick</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>W. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Tertiary Contacts Distant from the Active Site Prime a Ribozyme for Catalysis</article-title>. <source>Cell</source> <volume>126</volume> (<issue>2</issue>), <fpage>309</fpage>&#x2013;<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.06.036</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKay</surname>
<given-names>D. B.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Structure and Function of the Hammerhead Ribozyme: an Unfinished story</article-title>. <source>Rna</source> <volume>2</volume> (<issue>5</issue>), <fpage>395</fpage>&#x2013;<lpage>403</lpage>. </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Men&#xe9;ndez-Arias</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Decoding Molnupiravir-Induced Mutagenesis in SARS-CoV-2</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>297</volume> (<issue>1</issue>), <fpage>100867</fpage>. <pub-id pub-id-type="doi">10.1016/j.jbc.2021.100867</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mons</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dimicoli</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Piuzzi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tardivel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Elhanine</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Tautomerism of the DNA Base Guanine and its Methylated Derivatives as Studied by Gas-phase Infrared and Ultraviolet Spectroscopy</article-title>. <source>J.&#x20;Phys. Chem. A.</source> <volume>106</volume> (<issue>20</issue>), <fpage>5088</fpage>&#x2013;<lpage>5094</lpage>. <pub-id pub-id-type="doi">10.1021/jp0139742</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulder</surname>
<given-names>F. A. A.</given-names>
</name>
<name>
<surname>Mittermaier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dahlquist</surname>
<given-names>F. W.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>L. E.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Studying Excited States of Proteins by NMR Spectroscopy</article-title>. <source>Nat. Struct. Biol.</source> <volume>8</volume> (<issue>11</issue>), <fpage>932</fpage>&#x2013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1038/nsb1101-932</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullins</surname>
<given-names>J.&#x20;I.</given-names>
</name>
<name>
<surname>Heath</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Kicha</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Styrchak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K. G.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461</article-title>. <source>PloS one</source> <volume>6</volume> (<issue>1</issue>), <fpage>e15135</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0015135</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolova</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wise</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>O&#x2019;Brien</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Andricioaei</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Al-Hashimi</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Transient Hoogsteen Base Pairs in Canonical Duplex DNA</article-title>. <source>Nature</source> <volume>470</volume> (<issue>7335</issue>), <fpage>498</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nature09775</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Baiz</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Tokmakoff</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Direct Observation of Ground-State Lactam-Lactim Tautomerization Using Temperature-Jump Transient 2D IR Spectroscopy</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>110</volume> (<issue>23</issue>), <fpage>9243</fpage>&#x2013;<lpage>9248</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1303235110</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Fedeles</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Amariuta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Essigmann</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Two-dimensional IR Spectroscopy of the Anti-HIV Agent KP1212 Reveals Protonated and Neutral Tautomers that Influence pH-dependent Mutagenicity</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>112</volume> (<issue>11</issue>), <fpage>3229</fpage>&#x2013;<lpage>3234</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1415974112</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Tokmakoff</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Anharmonic Vibrational Modes of Nucleic Acid Bases Revealed by 2D IR Spectroscopy</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>133</volume> (<issue>39</issue>), <fpage>15650</fpage>&#x2013;<lpage>15660</lpage>. <pub-id pub-id-type="doi">10.1021/ja205636h</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Tokmakoff</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Identification of Lactam-Lactim Tautomers of Aromatic Heterocycles in Aqueous Solution Using 2D IR Spectroscopy</article-title>. <source>J.&#x20;Phys. Chem. Lett.</source> <volume>3</volume> (<issue>22</issue>), <fpage>3302</fpage>&#x2013;<lpage>3306</lpage>. <pub-id pub-id-type="doi">10.1021/jz301706a</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hampel</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Heckman</surname>
<given-names>J.&#x20;E.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Functional Involvement of G8 in the Hairpin Ribozyme Cleavage Mechanism</article-title>. <source>Embo j</source> <volume>20</volume> (<issue>22</issue>), <fpage>6434</fpage>&#x2013;<lpage>6442</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/20.22.6434</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangadurai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szymanski</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Kimsey</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Al-Hashimi</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Probing Conformational Transitions towards Mutagenic Watson-crick-like G&#xb7;T Mismatches Using Off-Resonance Sugar Carbon R1&#x3c1; Relaxation Dispersion</article-title>. <source>J.&#x20;Biomol. NMR</source> <volume>74</volume> (<issue>8-9</issue>), <fpage>457</fpage>&#x2013;<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1007/s10858-020-00337-7</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangadurai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Merriman</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Meiser</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Why Are Hoogsteen Base Pairs Energetically Disfavored in A-RNA Compared to B-DNA</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume> (<issue>20</issue>), <fpage>11099</fpage>&#x2013;<lpage>11114</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky885</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangadurai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Szymaski</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Kimsey</surname>
<given-names>I. J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Al-Hashimi</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Characterizing Micro-to-millisecond Chemical Exchange in Nucleic Acids Using Off-Resonance R1&#x3c1; Relaxation Dispersion</article-title>. <source>Prog. Nucl. Magn. Reson. Spectrosc.</source> <volume>112-113</volume>, <fpage>55</fpage>&#x2013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnmrs.2019.05.002</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rupert</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Ferr&#xe9;-D&#x27;Amar&#xe9;</surname>
<given-names>A. R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Crystal Structure of a Hairpin Ribozyme-Inhibitor Complex with Implications for Catalysis</article-title>. <source>Nature</source> <volume>410</volume> (<issue>6830</issue>), <fpage>780</fpage>&#x2013;<lpage>786</lpage>. <pub-id pub-id-type="doi">10.1038/35071009</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sevilla</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Besler</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Colson</surname>
<given-names>A.-O.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Ab Initio molecular Orbital Calculations of DNA Radical Ions. 5. Scaling of Calculated Electron Affinities and Ionization Potentials to Experimental Values</article-title>. <source>J.&#x20;Phys. Chem.</source> <volume>99</volume> (<issue>3</issue>), <fpage>1060</fpage>&#x2013;<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1021/j100003a032</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Selisko</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>N.-T. -T.</given-names>
</name>
<name>
<surname>Huchting</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Touret</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Piorkowski</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Rapid Incorporation of Favipiravir by the Fast and Permissive Viral RNA Polymerase Complex Results in SARS-CoV-2 Lethal Mutagenesis</article-title>. <source>Nat. Commun.</source> <volume>11</volume> (<issue>1</issue>), <fpage>4682</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-18463-z</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fedeles</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Essigmann</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Role of Tautomerism in RNA Biochemistry</article-title>. <source>Rna</source> <volume>21</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1261/rna.048371.114</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Silvestre</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Tokmakoff</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Direct Observation of Multiple Tautomers of Oxythiamine and Their Recognition by the Thiamine Pyrophosphate Riboswitch</article-title>. <source>ACS Chem. Biol.</source> <volume>9</volume> (<issue>1</issue>), <fpage>227</fpage>&#x2013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1021/cb400581f</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slocombe</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Al-Khalili</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Sacchi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Quantum And Classical Effects In DNA Point Mutations: Watson&#x2010;Crick Tautomerism In AT And GC Base Pairs</article-title>. <source>Phy. Chemi.</source> <volume>23</volume> (<issue>7</issue>), <fpage>4141</fpage>&#x2013;<lpage>4150</lpage>. <pub-id pub-id-type="doi">10.1039/D0CP05781A</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sood</surname>
<given-names>V. D.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Identification of the Catalytic Subdomain of the VS Ribozyme and Evidence for Remarkable Sequence Tolerance in the Active Site Loop</article-title>. <source>J.&#x20;Mol. Biol.</source> <volume>320</volume> (<issue>3</issue>), <fpage>443</fpage>&#x2013;<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-2836(02)00521-1</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suslov</surname>
<given-names>N. B.</given-names>
</name>
<name>
<surname>DasGupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fuller</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Lilley</surname>
<given-names>D. M. J.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>P. A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Crystal Structure of the Varkud Satellite Ribozyme</article-title>. <source>Nat. Chem. Biol.</source> <volume>11</volume> (<issue>11</issue>), <fpage>840</fpage>&#x2013;<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1929</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szymanski</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Kimsey</surname>
<given-names>I. J.</given-names>
</name>
<name>
<surname>Al-Hashimi</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Direct NMR Evidence that Transient Tautomeric and Anionic States in dG&#xb7;dT Form Watson-crick-like Base Pairs</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>139</volume> (<issue>12</issue>), <fpage>4326</fpage>&#x2013;<lpage>4329</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b01156</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Perrin</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Probing General Base Catalysis in the Hammerhead Ribozyme</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>130</volume> (<issue>46</issue>), <fpage>15467</fpage>&#x2013;<lpage>15475</lpage>. <pub-id pub-id-type="doi">10.1021/ja804496z</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thore</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Frick</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ban</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Structural Basis of Thiamine Pyrophosphate Analogues Binding to the Eukaryotic Riboswitch</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>130</volume> (<issue>26</issue>), <fpage>8116</fpage>&#x2013;<lpage>8117</lpage>. <pub-id pub-id-type="doi">10.1021/ja801708e</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thore</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Leibundgut</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ban</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Structure of the Eukaryotic Thiamine Pyrophosphate Riboswitch with its Regulatory Ligand</article-title>. <source>Science</source> <volume>312</volume> (<issue>5777</issue>), <fpage>1208</fpage>&#x2013;<lpage>1211</lpage>. <pub-id pub-id-type="doi">10.1126/science.1128451</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Topal</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Fresco</surname>
<given-names>J.&#x20;R.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>Complementary Base Pairing and the Origin of Substitution Mutations</article-title>. <source>Nature</source> <volume>263</volume> (<issue>5575</issue>), <fpage>285</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1038/263285a0</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velikyan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Acharya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Trifonova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>F&#xf6;ldesi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chattopadhyaya</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>The pKa&#x27;s of 2&#x27;-Hydroxyl Group in Nucleosides and Nucleotides</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>123</volume> (<issue>12</issue>), <fpage>2893</fpage>&#x2013;<lpage>2894</lpage>. <pub-id pub-id-type="doi">10.1021/ja0036312</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hellinga</surname>
<given-names>H. W.</given-names>
</name>
<name>
<surname>Beese</surname>
<given-names>L. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Structural Evidence for the Rare Tautomer Hypothesis of Spontaneous Mutagenesis</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>108</volume> (<issue>43</issue>), <fpage>17644</fpage>&#x2013;<lpage>17648</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1114496108</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watson</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Crick</surname>
<given-names>F. H. C.</given-names>
</name>
</person-group> (<year>1953</year>). <article-title>Genetical Implications of the Structure of Deoxyribonucleic Acid</article-title>. <source>Nature</source> <volume>171</volume> (<issue>4361</issue>), <fpage>964</fpage>&#x2013;<lpage>967</lpage>. <pub-id pub-id-type="doi">10.1038/171964b0</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilcox</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Bevilacqua</surname>
<given-names>P. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>A Simple Fluorescence Method for pKa Determination in RNA and DNA Reveals Highly Shifted pKa&#x27;s</article-title>. <source>J.&#x20;Am. Chem. Soc.</source> <volume>135</volume> (<issue>20</issue>), <fpage>7390</fpage>&#x2013;<lpage>7393</lpage>. <pub-id pub-id-type="doi">10.1021/ja3125299</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kimsey</surname>
<given-names>I. J.</given-names>
</name>
<name>
<surname>Nikolova</surname>
<given-names>E. N.</given-names>
</name>
<name>
<surname>Sathyamoorthy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Grazioli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McSally</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>m1A and m1G Disrupt A-RNA Structure through the Intrinsic Instability of Hoogsteen Base Pairs</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>23</volume> (<issue>9</issue>), <fpage>803</fpage>&#x2013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb.3270</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tse</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Woodburn</surname>
<given-names>B. M. D.</given-names>
</name>
<name>
<surname>Schinazi</surname>
<given-names>R. F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>&#x3b2;-DN 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 through Lethal Mutagenesis but Is Also Mutagenic to Mammalian Cells</article-title>. <source>J. Infect. Dis.</source> <volume>224</volume> (<issue>3</issue>), <fpage>415</fpage>&#x2013;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiab247</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>